TOP TIERMARKET NEWSWIRE
News & sentiment

ENANTA PHARMACEUTICA (ENTA) — News & AI sentiment

ENANTA PHARMACEUTICA (ENTA) news roundup. 1 story in the past week, 10 over 30 days. Average 30-day sentiment is 51/100. No insider transactions filed in the last 90 days. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
1
avg sentiment 52/100
30d stories
10
avg sentiment 51/100
Insider net (90d)
$0
0 buys · 0 sells
Congress (90d)
0
0 buys · 0 sells

ENTA news in the last 24 hours, 7 days, 30 days and 90 days

How much ENTA coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowENTA storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days152/100ENTA headlines →
Last 30 days1051/100ENTA headlines →
Last 90 days1551.7/100ENTA headlines →

Latest stories on ENTA

5d ago
Oct 29
Oct 29
Oct 28
Oct 28
Oct 28
Oct 28
Oct 26
Oct 26
Oct 13
Sep 28
Sep 28
Enanta Pharmaceuticals stock rating reiterated at Buy by H.C. Wainwright
Investing.com Analyst Ratings61 · neutralanalyst
Sep 23
Sep 21
Sep 1
Aug 10
Enanta Reports Q3 Eps 67c Consensus 51c
The Fly72 · bullishearnings
Aug 10
Aug 10
Aug 10
Jul 2
Jun 23
Jun 23
Jun 23
Jun 23
Jun 23
Open ENTA in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →